We are live on ! Find out more
BCM

Bronte Capital Management Portfolio holdings

AUM $1.01B
1-Year Est. Return 47.99%
This Fund
S&P 500
This Quarter Est. Return
+7.37%
1 Year Est. Return
+47.99%
3 Year Est. Return
+112.22%
5 Year Est. Return
+138.3%
10 Year Est. Return
AUM
$1.52B
AUM Growth
+$149M
Cap. Flow
+$202M
Cap. Flow %
13.36%
Top 10 Hldgs %
87.35%
Holding
30
New
3
Increased
10
Reduced
15
Closed
1

Sector Composition

Rank Sector Weight
1 Financials 18.89%
2 Communication Services 10.45%
3 Consumer Staples 10.21%
4 Healthcare 6.35%
5 Materials 3.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IWM icon
1
CALL
iShares Russell 2000 ETF
IWM
$79.8B
$399M 26.35%
177,900
+21,800
+14% +$4.93M
IWO icon
2
CALL
iShares Russell 2000 Growth ETF
IWO
$14.3B
$206M 13.61%
703,900
+241,200
+52% +$72.7M
GOOGL icon
3
Alphabet (Google) Class A
GOOGL
$4.36T
$142M 9.34%
977,840
-5,680
-0.6% -$818K
BRK.B icon
4
Berkshire Hathaway Class B
BRK.B
$1.1T
$124M 8.2%
415,836
-722
-0.2% -$207K
HLF icon
5
Herbalife
HLF
$1.29B
$113M 7.44%
2,755,572
+410,086
+17% +$17.1M
XBI icon
6
CALL
State Street SPDR S&P Biotech ETF
XBI
$9.95B
$106M 7%
+948,200
New +$114M
REGN icon
7
Regeneron Pharmaceuticals
REGN
$78.5B
$82.4M 5.43%
130,460
+6,236
+5% +$3.83M
IBKR icon
8
Interactive Brokers
IBKR
$39.2B
$68M 4.49%
3,427,140
-47,760
-1% -$889K
CTVA icon
9
Corteva
CTVA
$52.6B
$41.7M 2.75%
882,257
+22,261
+3% +$1.01M
V icon
10
Visa
V
$684B
$41.5M 2.74%
191,345
+13,905
+8% +$2.98M
BNY
11
Bank of New York Mellon
BNY
$106B
$27.9M 1.84%
481,240
-16,651
-3% -$958K
SPY icon
12
CALL
State Street SPDR S&P 500 ETF Trust
SPY
$790B
$27.2M 1.79%
5,700
-36,700
-87% -$16.8M
STT icon
13
State Street
STT
$50.6B
$24.6M 1.62%
264,779
-3,795
-1% -$358K
GHC icon
14
Graham Holdings Company
GHC
$5.1B
$18.6M 1.23%
29,595
+4,196
+17% +$2.47M
GOOG icon
15
Alphabet (Google) Class C
GOOG
$4.36T
$16.8M 1.11%
115,960
-23,480
-17% -$3.39M
MO icon
16
Altria Group
MO
$114B
$12.7M 0.84%
268,018
-19,543
-7% -$896K
GIS icon
17
General Mills
GIS
$19.1B
$11.3M 0.75%
168,374
-496
-0.3% -$31.5K
PM icon
18
Philip Morris
PM
$297B
$11.1M 0.73%
117,045
+10,752
+10% +$1M
SHC icon
19
Sotera Health
SHC
$5.09B
$9.34M 0.62%
396,667
+217,388
+121% +$5.2M
BYND icon
20
PUT
Beyond Meat
BYND
$292M
$6.52M 0.43%
100,000
MDLZ icon
21
Mondelez International
MDLZ
$79.5B
$5.87M 0.39%
88,471
+8,756
+11% +$540K
BBWI icon
22
Bath & Body Works
BBWI
$4.06B
$4.12M 0.27%
58,984
-810
-1% -$57.5K
SQM icon
23
Sociedad Química y Minera de Chile
SQM
$19.2B
$3.81M 0.25%
+75,627
New +$4.34M
NPO icon
24
Enpro
NPO
$6.63B
$3.26M 0.21%
29,599
-401
-1% -$40.3K
NEM icon
25
Newmont
NEM
$98.7B
$3.02M 0.2%
48,779
-24,142
-33% -$1.37M

Similar funds

Bronte Capital Management's Q4 2021 Portfolio in Review

As of Q4 2021, Bronte Capital Management held 30 positions worth $1.52B, up 11% from $1.37B the previous quarter. Its ten largest holdings account for 87% of the portfolio.

Bronte Capital Management deployed $202M of net new capital in Q4 2021, opening 3 new positions and adding to 10 existing holdings. Its largest new stake was Sociedad Química y Minera de Chile: 75,627 shares worth $3.81M.

By sector, the portfolio is most concentrated in Financials at 19% of assets, up from 19% a quarter earlier, followed by Communication Services and Consumer Staples.

On the sell side, the largest reduction was Alphabet (Google) Class C, an estimated $3.39M trimmed.

  • Bronte Capital Management's largest Q4 2021 buy was Sociedad Química y Minera de Chile: 75,627 shares worth $3.81M.
  • Bronte Capital Management added most to Herbalife in Q4 2021, an estimated $17.1M increase.
  • Bronte Capital Management's biggest Q4 2021 reduction was Alphabet (Google) Class C, cutting an estimated $3.39M.
  • Bronte Capital Management fully exited Vir Biotechnology in Q4 2021, selling an estimated $3.26M.
  • Bronte Capital Management's ten largest holdings make up 87% of its $1.52B portfolio in Q4 2021.
  • Bronte Capital Management opened 3 new positions and closed 1 in Q4 2021.
  • Bronte Capital Management's portfolio value rose 11% quarter-over-quarter to $1.52B.

Based on Bronte Capital Management's 13F filing for Q4 2021, filed 10 Feb 2022.